Last quarter (Q ), Lexaria Bioscience's total revenue was $151.28K, an increase of 49.08% from the same quarter last year. In Q, Lexaria Bioscience's net income was $-1.18M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Aug 23	Aug 22	Aug 21	Aug 20	Aug 19
Total Revenue	$ 174.53K	$ 226.21K	$ 255.40K	$ 722.74K	$ 384.54K	$ 222.61K
Cost of Revenue	$ 20.53K	$ 31.50K	$ 71.84K	$ 175.35K	$ 99.38K	$ 22.89K
Gross Profit	$ 154.01K	$ 194.71K	$ 183.56K	$ 547.39K	$ 215.41K	$ 199.72K
Operating Expense	$ 6.16M	$ 6.73M	$ 7.57M	$ 6.23M	$ 4.36M	$ 4.26M
Operating Income	$ -6.01M	$ -6.53M	$ -7.38M	$ -5.69M	$ -4.15M	$ -4.06M
Net Non Operating Interest Income Expense	$ 50.51K	$ 43.19K	-	-	-	-
Other Income Expense	$ 274.91K	$ 221.69K	-	$ 1.52M	$ -96.33K	$ -98.62K
Pretax Income	$ -6.23M	$ -6.71M	$ -7.38M	$ -4.16M	$ -4.15M	$ -4.16M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -6.19M	$ -6.66M	$ -7.27M	$ -4.03M	$ -3.93M	$ -4.10M
Basic EPS	$ -0.89	$ -1.01	$ -1.24	-	$ -1.47	$ -1.50
Diluted EPS	$ -0.89	$ -1.01	$ -1.24	-	$ -1.47	$ -1.50
Basic Average Shares	$ 29.56M	$ 6.61M	$ 5.89M	-	$ 2.77M	$ 2.59M
Diluted Average Shares	$ 29.56M	$ 6.61M	$ 5.89M	-	$ 2.77M	$ 2.59M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 6.18M	$ 6.76M	$ 7.64M	$ -6.41M	$ 4.46M	$ 4.28M
Net Income From Continuing And Discontinued Operation	$ -6.19M	$ -6.66M	$ -7.27M	$ -4.03M	$ -3.93M	$ -4.10M
Normalized Income	$ -4.88M	$ -4.93M	$ -5.43M	$ -4.58M	$ -4.00M	$ -4.00M
Interest Expense	-	-	-	-	-	-
EBIT	$ -6.23M	$ -6.71M	$ -7.38M	$ -4.16M	$ -4.15M	$ -4.06M
EBITDA	$ -6.08M	$ -6.57M	$ -7.24M	$ -4.02M	$ -4.00M	$ -4.00M

Currency in USD

Lexaria Bioscience Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing